KEY TAKEAWAY:Gilead, which recently acquired Kite Pharma in an all cash deal, said the list price for Yescarta, which is to be administered just once to each patient, would be $373,000. The cost is supposed to make us feel good because the price is well below that of the first drug in this new class such as $475,000 for Novartis’s Kymriah.
According to the Atlantic “opioid abuse is rampant in states like Ohio, where paramedics are increasingly spending time responding to overdoses and where coroners’ offices are running out of room to store bodies. In 2012, there were 793 million doses of opioids prescribed in the state, enough to supply every man, woman, and child, with 68 pills each”. But is pharma really to blame? Continue reading
KEY TAKEAWAY: According to STAT news “the music streaming service Pandora is helping pharma advertisers follow users around as they listen to music on different devices throughout the day”. What in hell makes anyone think that consumers want to be interrupted with a pharma ad while listening to music?
Key Takeaway:Our dietary habits are the leading driver of death and disability, causing an estimated 700,000 deaths each year. Poor diet causes nearly half of all US deaths due to heart disease, stroke and diabetes. There are almost 1,000 deaths from these causes alone, every day. Continue reading
KEY TAKEAWAY: Each disease condition has unique online characteristics with online health seekers. It’s a mistake to take any “generic” research and apply it all health conditions. Continue reading
KEY TAKEAWAY: Another casualty of the proposed healthcare legislation is pharma employees. Can you really be proud of an industry that is noted for obscene pricing and remaining silent during a proposed healthcare bill that could result in the death of thousands? Continue reading